Patriot Financial Group Insurance Agency’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-139
Closed -$4K 1649
2022
Q2
$4K Sell
139
-33
-19% -$1.11K ﹤0.01% 1574
2022
Q1
$6K Buy
172
+138
+406% +$5.19K ﹤0.01% 1560
2021
Q4
$1K Sell
34
-97
-74% -$4.06K ﹤0.01% 2070
2021
Q3
$6K Hold
131
﹤0.01% 1654
2021
Q2
$7K Buy
131
+48
+58% +$3.39K ﹤0.01% 1564
2021
Q1
$6K Sell
83
-4
-5% -$328 ﹤0.01% 1511
2020
Q4
$8K Hold
87
﹤0.01% 1302
2020
Q3
$5K Hold
87
﹤0.01% 1249
2020
Q2
$4K Hold
87
﹤0.01% 1258
2020
Q1
$2K Buy
+87
New +$5.04K ﹤0.01% 1332

Other funds holding SAGE

Patriot Financial Group Insurance Agency's SAGE Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Sage Therapeutics (SAGE) in Q3 2022, closing a stake of 139 shares — an estimated $4K sold.

Patriot Financial Group Insurance Agency first reported a position in SAGE in Q1 2020 and held it in 10 quarters. The position peaked at $8K in Q4 2020. 201 funds tracked by Wall St. Rank hold SAGE as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Sage Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 139 Sage Therapeutics shares in Q3 2022, an estimated $4K.
  • Patriot Financial Group Insurance Agency first reported a position in Sage Therapeutics in Q1 2020 and held it in 10 quarters.
  • Patriot Financial Group Insurance Agency's Sage Therapeutics position peaked at $8K in Q4 2020.
  • 201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.